{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:56:59Z","timestamp":1785542219783,"version":"3.56.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","sleep-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.sleep.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T07:04:31Z","timestamp":1425971071000},"page":"678-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Restless legs syndrome: clinical presentation diagnosis and treatment"],"prefix":"10.1016","volume":"16","author":[{"given":"Subhashie","family":"Wijemanne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2015.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ncl.2012.08.004","article-title":"Restless legs syndrome and periodic leg movements of sleep","volume":"30","author":"Rye","year":"2012","journal-title":"Neurol Clin"},{"key":"10.1016\/j.sleep.2015.03.002_bib0015","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00415-010-5644-y","article-title":"Impairment of sensory-motor integration in patients affected by RLS","volume":"257","author":"Rizzo","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(13)70213-8","article-title":"Sensory aspects of movement disorders","volume":"13","author":"Patel","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.sleep.2013.09.030","article-title":"Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging","volume":"15","author":"Ku","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.sleep.2004.01.002","article-title":"Restless legs syndrome: an historical note","volume":"5","author":"Coccagna","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2015.03.002_bib0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria \u2013 history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1586\/14737175.2014.927734","article-title":"Differentiating nocturnal leg cramps and restless legs syndrome","volume":"14","author":"Rana","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.sleep.2015.03.002_bib0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/WNL.47.6.1435","article-title":"Restless legs syndrome: clinicoetiologic correlates","volume":"47","author":"Ondo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.sleep.2011.11.020","article-title":"Descriptors of restless legs syndrome sensations","volume":"13","author":"Kerr","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2012.05.051","article-title":"Topography of the sensations in primary restless legs syndrome","volume":"320","author":"Karroum","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.sleep.2015.03.002_bib0075","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(09)70183-8","article-title":"Treatment of hyperkinetic movement disorders","volume":"8","author":"Jankovic","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0080","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/mds.20969","article-title":"Validation of the \u201cL-DOPA test\u201d for diagnosis of restless legs syndrome","volume":"21","author":"Stiasny-Kolster","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.870120111","article-title":"Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria","volume":"12","author":"Montplaisir","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0090","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5665\/sleep.1986","article-title":"The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline","volume":"35","author":"Aurora","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/smrv.2001.0193","article-title":"Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder","volume":"6","author":"Stiasny","year":"2002","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2015.03.002_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.sleep.2006.01.001","volume":"7","author":"Zucconi","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.sleep.2012.08.014","article-title":"Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index","volume":"14","author":"Ferri","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.sleep.2010.07.007","article-title":"Restless legs syndrome: understanding its consequences and the need for better treatment","volume":"11","author":"Earley","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0149-2918(04)90136-1","article-title":"Evaluating the quality of life of patients with restless legs syndrome","volume":"26","author":"Abetz","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2015.03.002_bib0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.23430","article-title":"Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States","volume":"26","author":"Allen","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1176\/appi.neuropsych.12120394","article-title":"Comparison of cognitive functioning among individuals with treated restless legs syndrome (RLS), untreated RLS, and no RLS","volume":"26","author":"Lee","year":"2014","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2015.03.002_bib0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2010.55","article-title":"Restless legs syndrome: pathophysiology, clinical presentation and management","volume":"6","author":"Trenkwalder","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0135","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ene.12545","article-title":"Restless legs syndrome is associated with cardio\/cerebrovascular events and mortality in end-stage renal disease","volume":"22","author":"Lin","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001652","article-title":"Restless legs syndrome and all-cause mortality in four prospective cohort studies","volume":"2","author":"Szentkiralyi","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.sleep.2015.03.002_bib0145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1212\/WNL.0b013e318297eee0","article-title":"Prospective study of restless legs syndrome and mortality among men","volume":"81","author":"Li","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0150","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mds.1102","article-title":"Restless legs syndrome in an Asian population: a study in Singapore","volume":"16","author":"Tan","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0160","first-page":"1069","article-title":"Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders","volume":"32","author":"Cho","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.smrv.2011.05.002","article-title":"Epidemiology of restless legs syndrome: a synthesis of the literature","volume":"16","author":"Ohayon","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2015.03.002_bib0170","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.WNL.0000163996.64461.A3","article-title":"Restless legs syndrome: a community-based study of prevalence, severity, and risk factors","volume":"64","author":"Hogl","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archneur.59.3.421","article-title":"Exploring the relationship between Parkinson disease and restless legs syndrome","volume":"59","author":"Ondo","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0180","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.parkreldis.2012.12.005","article-title":"Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study","volume":"19","author":"Bhalsing","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2047-9158-1-6","article-title":"Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence","volume":"1","author":"Peeraully","year":"2012","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.sleep.2015.03.002_bib0190","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jamaneurol.2014.1326","article-title":"Restless genital syndrome in Parkinson disease","volume":"71","author":"Aquino","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5665\/sleep.3416","article-title":"Restless legs syndrome: an early clinical feature of Parkinson disease in men","volume":"37","author":"Wong","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/sleep\/23.5.1b","article-title":"Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients","volume":"23","author":"Winkelmann","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/1531-8257(199901)14:1<111::AID-MDS1018>3.0.CO;2-9","article-title":"Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees","volume":"14","author":"Lazzarini","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJMoa072743","article-title":"A genetic risk factor for periodic limb movements in sleep","volume":"357","author":"Stefansson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0215","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng2099","article-title":"Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions","volume":"39","author":"Winkelmann","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.sleep.2015.03.002_bib0220","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ng.190","article-title":"PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome","volume":"40","author":"Schormair","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.sleep.2015.03.002_bib0225","doi-asserted-by":"crossref","first-page":"e1002171","DOI":"10.1371\/journal.pgen.1002171","article-title":"Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1","volume":"7","author":"Winkelmann","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.sleep.2015.03.002_bib0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.conb.2013.07.001","article-title":"The molecular basis of restless legs syndrome","volume":"23","author":"Freeman","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0235","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1468-1331.2011.03604.x","article-title":"Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients","volume":"19","author":"Rizzo","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0240","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.sleep.2010.10.009","article-title":"Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome","volume":"12","author":"Connor","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.sleep.2006.09.010","article-title":"Voxel-based morphometry in unmedicated patients with restless legs syndrome","volume":"9","author":"Hornyak","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0250","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3174\/ajnr.A2829","article-title":"Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours","volume":"33","author":"Margariti","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0255","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000325914.50764.a2","article-title":"T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome","volume":"71","author":"Astrakas","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.56.2.263","article-title":"MRI measurement of brain iron in patients with restless legs syndrome","volume":"56","author":"Allen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0265","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11910-013-0372-1","article-title":"Imaging brain functional and metabolic changes in restless legs syndrome","volume":"13","author":"Rizzo","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.sleep.2013.09.030","article-title":"Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging","volume":"15","author":"Ku","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5665\/sleep.2300","article-title":"Increased synaptic dopamine in the putamen in restless legs syndrome","volume":"36","author":"Earley","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0280","series-title":"Restless legs","author":"Ekbom","year":"1945"},{"key":"10.1016\/j.sleep.2015.03.002_bib0285","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/brain\/awr012","article-title":"Profile of altered brain iron acquisition in restless legs syndrome","volume":"134","author":"Connor","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2015.03.002_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.12.054","article-title":"Iron dysregulation in movement disorders","volume":"46","author":"Dusek","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2015.03.002_bib0295","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome","volume":"14","author":"Mizuno","year":"2005","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2015.03.002_bib0305","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000078887.16593.12","article-title":"Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome","volume":"61","author":"Connor","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/sleep\/28.9.1069","article-title":"Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes","volume":"28","author":"Earley","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0315","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.expneurol.2014.06.023","article-title":"Low brain iron effects and reversibility on striatal dopamine dynamics","volume":"261","author":"Unger","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/WNL.0b013e31829a33bd","article-title":"Predictors of placebo response in restless legs syndrome studies","volume":"81","author":"Ondo","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0325","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/brain\/awm244","article-title":"Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies","volume":"131","author":"Fulda","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2015.03.002_bib0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13311-013-0247-9","article-title":"Treatment of restless legs syndrome","volume":"11","author":"Comella","year":"2014","journal-title":"Neurother"},{"key":"10.1016\/j.sleep.2015.03.002_bib0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"issue":"Suppl. 18","key":"10.1016\/j.sleep.2015.03.002_bib0340","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1002\/mds.21588","article-title":"Assessment of restless legs syndrome\u2013methodological approaches for use in practice and clinical trials","volume":"22","author":"Kohnen","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0345","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1389-9457(00)00080-0","article-title":"Validation of the Johns Hopkins restless legs severity scale","volume":"2","author":"Allen","year":"2001","journal-title":"Sleep Med"},{"issue":"Suppl. 2","key":"10.1016\/j.sleep.2015.03.002_bib0350","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.sleep.2007.04.008","article-title":"RLS assessment and sleep questionnaires in practice\u2013lessons learned from Parkinson's disease","volume":"8","author":"Hogl","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0355","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.sleep.2013.09.008","article-title":"Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire","volume":"14","author":"Allen","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0360","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3122\/jabfm.19.5.487","article-title":"Exercise and restless legs syndrome: a randomized controlled trial","volume":"19","author":"Aukerman","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0365","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s13311-012-0139-4","article-title":"Strategies for the treatment of restless legs syndrome","volume":"9","author":"Buchfuhrer","year":"2012","journal-title":"Neurother"},{"key":"10.1016\/j.sleep.2015.03.002_bib0370","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1378\/chest.08-1665","article-title":"Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial","volume":"135","author":"Lettieri","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2015.03.002_bib0375","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006457.pub2","article-title":"Acupuncture for restless legs syndrome","author":"Cui","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sleep.2015.03.002_bib0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/09593985.2010.511440","article-title":"Restless legs syndrome and near-infrared light: an alternative treatment option","volume":"27","author":"Mitchell","year":"2011","journal-title":"Physiother Theory Pract"},{"key":"10.1016\/j.sleep.2015.03.002_bib0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/NDT.S19177","article-title":"Nondrug-related aspect of treating Ekbom disease, formerly known as restless legs syndrome","volume":"7","author":"Mitchell","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.sleep.2015.03.002_bib0390","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/jamainternmed.2013.3733","article-title":"Pharmacologic therapy for primary restless legs syndrome: a systematic review and meta-analysis","volume":"173","author":"Wilt","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0395","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.sleep.2011.09.013","article-title":"Efficacy and safety of dopamine agonists in restless legs syndrome","volume":"13","author":"Hornyak","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sleep.2010.03.019","article-title":"Effects of acute dopamine-agonist treatment in restless legs syndrome on heart rate variability during sleep","volume":"12","author":"Manconi","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0405","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.sleep.2011.03.003","article-title":"Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0410","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"12","author":"Silver","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0415","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0420","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","article-title":"Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists","volume":"68","author":"Tippmann-Peikert","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0425","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/mds.24889","article-title":"Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks","volume":"27","author":"Garcia-Borreguero","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0430","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.002_bib0435","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/mds.20257","article-title":"Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study","volume":"19","author":"Walters","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0440","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/sleep\/27.5.907","article-title":"Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome","volume":"27","author":"Allen","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0445","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/mds.22254","article-title":"Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice","volume":"23","author":"Trenkwalder","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0450","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group","volume":"14","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0455","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.sleep.2010.12.007","article-title":"Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome","volume":"12","author":"Hogl","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0460","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sleep.2006.03.011","article-title":"Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study\u2013the PRELUDE study","volume":"7","author":"Partinen","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0465","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.21261","article-title":"Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study)","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0470","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/sleep\/26.7.819","article-title":"Pramipexole in the management of restless legs syndrome: an extended study","volume":"26","author":"Silber","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0475","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.sleep.2012.08.004","article-title":"Long-term use of pramipexole in the management of restless legs syndrome","volume":"13","author":"Lipford","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0480","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1303646","article-title":"Comparison of pregabalin with pramipexole for restless legs syndrome","volume":"370","author":"Allen","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0485","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.sleep.2007.11.020","article-title":"Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome","volume":"9","author":"Quilici","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0490","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.20251","article-title":"Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study","volume":"19","author":"Stiasny-Kolster","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0495","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.sleep.2008.04.012","article-title":"One year open-label safety and efficacy trial with rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome","volume":"9","author":"Oertel","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0500","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.23157","article-title":"Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States","volume":"25","author":"Hening","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0505","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.sleep.2010.02.014","article-title":"Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study","volume":"11","author":"Oertel","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0510","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1474-4422(11)70127-2","article-title":"Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study","volume":"10","author":"Oertel","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0515","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1517\/14656566.8.9.1329","article-title":"Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome","volume":"8","author":"Kenney","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.sleep.2015.03.002_bib0520","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.sleep.2011.09.016","article-title":"Augmentation in the treatment of restless legs syndrome with transdermal rotigotine","volume":"13","author":"Benes","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0525","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pnpbp.2012.10.012","article-title":"Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome","volume":"40","author":"Inoue","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.002_bib0530","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2377-12-106","article-title":"Transdermal rotigotine for the perioperative management of restless legs syndrome","volume":"12","author":"Hogl","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0535","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1212\/01.wnl.0000237742.08297.22","article-title":"Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)","volume":"67","author":"Oertel","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0540","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/01.WNL.0000124465.20878.84","article-title":"Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study","volume":"62","author":"Trenkwalder","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0545","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.62.8.1290","article-title":"Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease","volume":"62","author":"Tintner","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0550","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.22385","article-title":"Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists","volume":"24","author":"Andersohn","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0555","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/sleep\/18.8.681","article-title":"L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial","volume":"18","author":"Trenkwalder","year":"1995","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0560","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/mds.10503","article-title":"One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?","volume":"18","author":"Trenkwalder","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0565","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.1990.00530110083021","article-title":"Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up","volume":"47","author":"von Scheele","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0570","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/19.3.205","article-title":"Augmentation of the restless legs syndrome with carbidopa\/levodopa","volume":"19","author":"Allen","year":"1996","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0575","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mds.21401","article-title":"Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial","volume":"22","author":"Trenkwalder","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0580","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.sleep.2008.09.007","article-title":"The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels","volume":"10","author":"Frauscher","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0585","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.sleep.2015.03.002_bib0590","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2\u2009+\u2009channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.sleep.2015.03.002_bib0595","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"issue":"Suppl. 18","key":"10.1016\/j.sleep.2015.03.002_bib0600","doi-asserted-by":"crossref","first-page":"S466","DOI":"10.1002\/mds.21545","article-title":"State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome","volume":"22","author":"Oertel","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0605","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4065\/79.7.916","article-title":"An algorithm for the management of restless legs syndrome","volume":"79","author":"Silber","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2015.03.002_bib0610","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00702-009-0361-3","article-title":"Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome","volume":"117","author":"Saletu","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.sleep.2015.03.002_bib0615","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","article-title":"Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study","volume":"59","author":"Garcia-Borreguero","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0620","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.clinthera.2009.07.026","article-title":"Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers","volume":"31","author":"Lal","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.sleep.2015.03.002_bib0625","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/0091270008322909","article-title":"Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin","volume":"48","author":"Cundy","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0630","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0b013e318259eac8","article-title":"A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome","volume":"35","author":"Lal","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0635","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/sleep\/32.2.159","article-title":"A randomized, double-blind, placebo-controlled, crossover study of XP13512\/GSK1838262 in the treatment of patients with primary restless legs syndrome","volume":"32","author":"Kushida","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0640","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/WNF.0b013e3181b3ab16","article-title":"Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Walters","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0645","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4065\/mcp.2009.0700","article-title":"Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study","volume":"85","author":"Bogan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2015.03.002_bib0650","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WNF.0b013e3182087d48","article-title":"A 52-week study of gabapentin enacarbil in restless legs syndrome","volume":"34","author":"Ellenbogen","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0655","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/jcm7090282","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome","volume":"7","author":"Lee","year":"2011","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0660","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/mds.23771","article-title":"Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome","volume":"26","author":"Winkelman","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0665","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pnpbp.2011.10.009","article-title":"Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients","volume":"36","author":"Inoue","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.002_bib0670","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1468-1331.2012.03853.x","article-title":"European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society","volume":"19","author":"Garcia-Borreguero","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0675","author":"XenoPort I"},{"key":"10.1016\/j.sleep.2015.03.002_bib0680","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/NDT.S30160","article-title":"Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200\u2009mg dose?","volume":"10","author":"Kume","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.sleep.2015.03.002_bib0685","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.2007.00796.x","article-title":"Pregabalin in restless legs syndrome with and without neuropathic pain","volume":"115","author":"Sommer","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2015.03.002_bib0690","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.0b013e3181e1ce73","article-title":"Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study","volume":"74","author":"Garcia-Borreguero","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0695","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sleep.2010.03.003","article-title":"A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0700","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMe1313155","article-title":"Therapeutic dilemma for restless legs syndrome","volume":"370","author":"Chokroverty","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0705","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3182662098","article-title":"Endogenous opioid systems: current concepts and clinical correlations","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0710","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","article-title":"Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension","volume":"12","author":"Trenkwalder","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0715","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/brain\/awh441","article-title":"The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study","volume":"128","author":"von Spiczak","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.sleep.2015.03.002_bib0720","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2008.12.022","article-title":"Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study","volume":"279","author":"Walters","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.sleep.2015.03.002_bib0725","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.21342","article-title":"Augmentation of restless legs syndrome with long-term tramadol treatment","volume":"22","author":"Vetrugno","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0730","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.sleep.2006.05.011","article-title":"Restless legs syndrome augmentation associated with tramadol","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0735","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/sleep\/16.4.327","article-title":"Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo","volume":"16","author":"Walters","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0740","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/sleep\/16.8.717","article-title":"A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa\/levodopa and propoxyphene","volume":"16","author":"Kaplan","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0745","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0750","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.20359","article-title":"Methadone for refractory restless legs syndrome","volume":"20","author":"Ondo","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0755","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.sleep.2008.11.003","article-title":"Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study","volume":"10","author":"Wang","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0760","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000008138","article-title":"A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome","volume":"43","author":"Davis","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0765","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.sleep.2007.07.020","article-title":"Augmentation in restless legs syndrome is associated with low ferritin","volume":"9","author":"Trenkwalder","year":"2008","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0770","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.sleep.2004.03.002","article-title":"The treatment of restless legs syndrome with intravenous iron dextran","volume":"5","author":"Earley","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0775","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.sleep.2009.12.002","article-title":"Intravenous iron dextran for severe refractory restless legs syndrome","volume":"11","author":"Ondo","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0780","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0785","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0790","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.sleep.2012.11.001","article-title":"Lower molecular weight intravenous iron dextran for restless legs syndrome","volume":"14","author":"Cho","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0795","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ajh.20056","article-title":"Parenteral iron therapy options","volume":"76","author":"Silverstein","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0800","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.sleep.2007.03.022","article-title":"Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute","volume":"8","author":"Garcia-Borreguero","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0805","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.sleep.2011.03.003","article-title":"Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0810","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.sleep.2010.08.001","article-title":"Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials","volume":"11","author":"Garcia-Borreguero","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0815","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.43.2.445","article-title":"Dopaminergic treatment of restless legs and rebound phenomenon","volume":"43","author":"Guilleminault","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0820","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1592\/phco.28.2.271","article-title":"Restless legs syndrome induced by escitalopram: case report and review of the literature","volume":"28","author":"Page","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sleep.2015.03.002_bib0825","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3999(02)00443-9","article-title":"Prevalence of restless legs syndrome and periodic limb movement disorder in the general population","volume":"53","author":"Ohayon","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.sleep.2015.03.002_bib0830","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpsychires.2008.02.006","article-title":"Restless legs syndrome as side effect of second generation antidepressants","volume":"43","author":"Rottach","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.sleep.2015.03.002_bib0835","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4088\/JCP.v58n0803","article-title":"Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers","volume":"58","author":"Salin-Pascual","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2015.03.002_bib0840","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0032-1331702","article-title":"The influence of the tricyclic antidepressant amitriptyline on periodic limb movements during sleep","volume":"46","author":"Goerke","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.sleep.2015.03.002_bib0845","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.27716","article-title":"Pharmacologically induced\/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder\/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis","volume":"6","author":"Hoque","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0850","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.36076\/ppj.2009\/12\/1013","article-title":"Proton pump inhibitors and pain","volume":"12","author":"Smith","year":"2009","journal-title":"Pain Physician"},{"key":"10.1016\/j.sleep.2015.03.002_bib0855","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-3148.2000.00239.x","article-title":"Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors","volume":"10","author":"Alvarez-Ossorio","year":"2000","journal-title":"Transfus Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0860","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/mds.25576","article-title":"Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging","volume":"28","author":"Rizzo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0865","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajh.23397","article-title":"The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia","volume":"88","author":"Allen","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0870","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mds.870130220","article-title":"Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome","volume":"13","author":"Montplaisir","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0875","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.5665\/sleep.2820","article-title":"Validation of the Multiple Suggested Immobilization Test: A Test for the Assessment of Severity of Restless Legs Syndrome (Willis-Ekbom Disease)","volume":"36","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib0880","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1517\/14656566.2014.908850","article-title":"Pharmacotherapy for restless legs syndrome","volume":"15","author":"Ferini-Strambi","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 18","key":"10.1016\/j.sleep.2015.03.002_bib0885","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1002\/mds.21610","article-title":"Augmentation as a treatment complication of restless legs syndrome: concept and management","volume":"22","author":"Garcia-Borreguero","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0890","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.sleep.2014.01.016","article-title":"Polysomnographic record and successful management of augmentation in restless legs syndrome\/Willis-Ekbom disease","volume":"15","author":"Maestri","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0895","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JPRLS.S47648","article-title":"Augmentation in restless legs syndrome: poor response to sudden withdrawal of dopaminergic therapy","volume":"3","author":"Kurlan","year":"2013","journal-title":"J Parkinsonism Restless Legs Syndr"},{"key":"10.1016\/j.sleep.2015.03.002_bib0900","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1111\/j.1525-1497.2006.00593.x","article-title":"Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation","volume":"21","author":"Kurlan","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0905","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11940-014-0317-2","article-title":"Restless legs syndrome: pathophysiology and treatment","volume":"16","author":"Ondo","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0910","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1001\/jama.295.24.2851","article-title":"Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial","volume":"295","author":"Sivertsen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2015.03.002_bib0915","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1378\/chest.12-0731","article-title":"Cognitive behavioral treatment of insomnia","volume":"143","author":"Williams","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.sleep.2015.03.002_bib0920","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","article-title":"Insomnia","volume":"309","author":"Buysse","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2015.03.002_bib0925","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.sleep.2008.05.014","article-title":"A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance","volume":"10","author":"Jama","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0930","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4065\/81.1.17","article-title":"Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial","volume":"81","author":"Bogan","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.sleep.2015.03.002_bib0935","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000072882","article-title":"Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome","volume":"48","author":"Happe","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0940","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-977X(01)00080-3","article-title":"Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam","volume":"11","author":"Saletu","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0945","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1227\/01.NEU.0000311089.04014.91","article-title":"Control of medically refractory restless legs syndrome with intrathecal morphine: case report","volume":"62","author":"Ross","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.sleep.2015.03.002_bib0950","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1227\/01.NEU.0000325674.02282.CC","article-title":"Intrathecal morphine as a treatment for refractory restless legs syndrome","volume":"63","author":"Lindvall","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.sleep.2015.03.002_bib0955","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1399-6576.2002.460121.x","article-title":"Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery","volume":"46","author":"Jakobsson","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.sleep.2015.03.002_bib0960","first-page":"2250","article-title":"Intrathecal morphine infusion a possible treatment in restless legs]","volume":"104","author":"Lindvall","year":"2007","journal-title":"Lakartidningen"},{"key":"10.1016\/j.sleep.2015.03.002_bib0965","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0404.2012.01707.x","article-title":"Overall self-perceived health in Restless legs treated with intrathecal morphine","volume":"127","author":"Lindvall","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2015.03.002_bib0970","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1212\/WNL.0b013e318278b5e7","article-title":"Long-Term treatment of a patient with severe restless legs syndrome using intrathecal morphine","volume":"79","author":"Hornyak","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0975","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.sleep.2012.06.007","article-title":"Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome","volume":"13","author":"Ondo","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib0980","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.20349","article-title":"Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia","volume":"20","author":"Okun","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib0985","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1531-8249(199911)46:5<800::AID-ANA22>3.0.CO;2-F","article-title":"Amelioration of sensory limb discomfort of restless legs syndrome by pallidotomy","volume":"46","author":"Rye","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib0990","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1212\/01.WNL.0000147288.26029.B8","article-title":"Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease","volume":"63","author":"Kedia","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2015.03.002_bib0995","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/mds.20911","article-title":"Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation","volume":"21","author":"Driver-Dunckley","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib1000","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.parkreldis.2004.10.015","article-title":"VIM deep brain stimulation does not improve pre-existing restless legs syndrome in patients with essential tremor","volume":"12","author":"Ondo","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib1005","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.parkreldis.2014.03.027","article-title":"Restless legs syndrome and pregnancy: A review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib1010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/sleep\/27.2.350","article-title":"Restless legs syndrome among pregnant women","volume":"27","author":"Manconi","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib1015","first-page":"101","article-title":"Restless legs syndrome: pathophysiology and the role of iron and folate","volume":"12","author":"Patrick","year":"2007","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.sleep.2015.03.002_bib1020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.sleep.2013.08.778","article-title":"Pediatric restless legs syndrome diagnostic criteria: an update by the International Restless Legs Syndrome Study Group","volume":"14","author":"Picchietti","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib1025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2006-2767","article-title":"Restless legs syndrome: prevalence and impact in children and adolescents \u2013 the Peds REST study","volume":"120","author":"Picchietti","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.sleep.2015.03.002_bib1030","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/sleep\/27.8.1499","article-title":"Symptoms of attention-deficit\/hyperactivity disorder in adults with restless legs syndrome","volume":"27","author":"Wagner","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.03.002_bib1035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.213.269","article-title":"Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder","volume":"213","author":"Oner","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib1040","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.sleep.2009.04.003","article-title":"Sleep disorders in children with Attention-Deficit\/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography","volume":"10","author":"Silvestri","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib1045","article-title":"Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children","volume":"45","author":"Newcorn","year":"1998","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.sleep.2015.03.002_bib1050","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1542\/peds.111.5.e628","article-title":"Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians","volume":"111","author":"Owens","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.sleep.2015.03.002_bib1055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.sleep.2009.11.014","article-title":"Advances in pediatric restless legs syndrome: iron, genetics, diagnosis and treatment","volume":"11","author":"Picchietti","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.03.002_bib1060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.20292","article-title":"Childhood-onset restless legs syndrome","volume":"56","author":"Kotagal","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib1065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/mds.22016","article-title":"Childhood-onset restless legs syndrome: clinical and genetic features of 22 families","volume":"23","author":"Muhle","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2015.03.002_bib1070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2004.11.007","article-title":"Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome","volume":"32","author":"Konofal","year":"2005","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib1075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0887-8994(99)00152-6","article-title":"Dopaminergic therapy in children with restless legs\/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group","volume":"22","author":"Walters","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.sleep.2015.03.002_bib1080","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/apa.12173","article-title":"Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment","volume":"102","author":"Tilma","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.sleep.2015.03.002_bib1085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/pch\/17.4.193","article-title":"Iron's role in paediatric restless legs syndrome \u2013 a review","volume":"17","author":"Dosman","year":"2012","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.sleep.2015.03.002_bib1090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.sleep.2013.06.006","article-title":"Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose","volume":"14","author":"Grim","year":"2013","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T19:58:54Z","timestamp":1651435134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945715006474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":216,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1389945715006474"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2015.03.002","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restless legs syndrome: clinical presentation diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}